This inventor holds 16 USPTO granted patents. Top assignees: Oncoimmunin Inc., Johns Hopkins University, Oncolmmunin Inc.. Active years: 1988-2022.
Location History:
- Baltimore, MD (US) (1988 - 1991)
- Rockville, MD (US) (1994 - 2009)
- Potomac, MD (US) (2007 - 2022)
Company Filing History:
9 out of 9 
3 out of 3,798 
2 out of 2 
Years Active: 1988-2022
Title: The Innovative Journey of Beverly S. Packard
Introduction
Beverly S. Packard, based in Rockville, MD, is a prolific inventor known for her significant contributions to the field of biochemistry and molecular biology. With a remarkable portfolio of 16 patents, Beverly's work has advanced the methodologies for delivering genetic material, making substantial impacts on various biological research applications.
Latest Patents
One of Beverly's latest patents focuses on the "In vivo delivery of oligonucleotides." This groundbreaking invention provides a sophisticated method for delivering nucleic acid sequences into the cytoplasm of cells and tissues within living organisms. Utilizing the presence of hydroxyethyl starch (HES) linked to oligonucleotides, her method ensures that the delivery vehicle remains nontoxic to cells and organisms. The sequence-independent delivery system crosses cellular membranes in a receptor-independent fashion, allowing for targeted interactions with complementary sequences in both cytoplasm and nucleus. This innovation holds promise for the delivery of various nucleic acid sequences, including genes coding for specific proteins, antisense oligonucleotides, siRNAs, shRNAs, and many more across diverse living organisms such as mammals, plants, and microorganisms.
Career Highlights
Beverly has made her mark in notable institutions, contributing her expertise at Oncoimmunin Inc. and The Johns Hopkins University. Her research in these organizations has been recognized for its potential applications in medical and therapeutic fields, especially concerning genetic therapies.
Collaborations
Throughout her career, Beverly collaborated with several prominent professionals, including Akira Komoriya and Michael Edidin. These partnerships have fostered an environment of innovation, enabling the exploration of cutting-edge technologies in molecular delivery systems.
Conclusion
Beverly S. Packard remains a vital figure in the landscape of genetic research and molecular biology. Her patents not only showcase her inventive spirit but also demonstrate her commitment to advancing the field through innovative solutions. As she continues her work, the implications of her discoveries are likely to inspire further advancements in the delivery of nucleic acids, potentially transforming therapeutic practices in modern medicine.